179 related articles for article (PubMed ID: 15182128)
1. Variable parathyroid hormone(1-84)/carboxylterminal PTH ratios detected by 4 novel parathyroid hormone assays.
Koller H; Zitt E; Staudacher G; Neyer U; Mayer G; Rosenkranz AR
Clin Nephrol; 2004 May; 61(5):337-43. PubMed ID: 15182128
[TBL] [Abstract][Full Text] [Related]
2. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
Reichel H; Esser A; Roth HJ; Schmidt-Gayk H
Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646
[TBL] [Abstract][Full Text] [Related]
3. Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease.
Herberth J; Fahrleitner-Pammer A; Obermayer-Pietsch B; Krisper P; Holzer H; Malluche HH; Dobnig H
Clin Nephrol; 2006 May; 65(5):328-34. PubMed ID: 16724653
[TBL] [Abstract][Full Text] [Related]
4. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions.
Cantor T; Yang Z; Caraiani N; Ilamathi E
Clin Chem; 2006 Sep; 52(9):1771-6. PubMed ID: 16858070
[TBL] [Abstract][Full Text] [Related]
5. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure.
John MR; Goodman WG; Gao P; Cantor TL; Salusky IB; Jüppner H
J Clin Endocrinol Metab; 1999 Nov; 84(11):4287-90. PubMed ID: 10566687
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 1-84 and intact parathyroid hormone assay in pediatric dialysis patients.
Sheth RD; Goldstein SL
Pediatr Nephrol; 2005 Jul; 20(7):977-81. PubMed ID: 15856315
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the intact PTH test with the total PTH test in hemodialyzed patients].
Pecovnik Balon B; Puklavec L; Hojs R
Acta Med Croatica; 2003; 57(1):69-70. PubMed ID: 12876868
[TBL] [Abstract][Full Text] [Related]
8. Two-site immunoradiometric intact parathyroid hormone assay versus C-terminal parathyroid hormone in predicting osteodystrophic bone lesions in predialysis chronic renal failure.
Coen G; Mazzaferro S; Ballanti P; Bonucci E; Cinotti GA; Fondi G; Manni M; Pasquali M; Perruzza I; Sardella D
J Lab Clin Med; 1993 Jul; 122(1):103-9. PubMed ID: 8320484
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
Ziółkowska H; Roszkowska-Blaim M
Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516
[TBL] [Abstract][Full Text] [Related]
10. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
[TBL] [Abstract][Full Text] [Related]
11. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.
Salusky IB; Goodman WG; Kuizon BD; Lavigne JR; Zahranik RJ; Gales B; Wang HJ; Elashoff RM; Jüppner H
Kidney Int; 2003 May; 63(5):1801-8. PubMed ID: 12675856
[TBL] [Abstract][Full Text] [Related]
12. Measurement of PTH fragments for assessment of renal bone disease in hemodialysis patients.
Fehr T; Garzoni D; Staub T; Binet I; Wüthrich RP
Kidney Blood Press Res; 2006; 29(3):175-81. PubMed ID: 16931896
[TBL] [Abstract][Full Text] [Related]
13. A novel mechanism for skeletal resistance in uremia.
Slatopolsky E; Finch J; Clay P; Martin D; Sicard G; Singer G; Gao P; Cantor T; Dusso A
Kidney Int; 2000 Aug; 58(2):753-61. PubMed ID: 10916099
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone and its fragments in children with chronic renal failure.
Waller S; Reynolds A; Ridout D; Cantor T; Gao P; Rees L
Pediatr Nephrol; 2003 Dec; 18(12):1242-8. PubMed ID: 14579141
[TBL] [Abstract][Full Text] [Related]
15. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
Inaba M; Okuno S; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y
Osteoporos Int; 2005 May; 16(5):517-25. PubMed ID: 15322741
[TBL] [Abstract][Full Text] [Related]
16. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
Cantor T; Sci B
Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
[TBL] [Abstract][Full Text] [Related]
17. A lower proportion of circulating active parathyroid hormone in peritoneal dialysis does not allow the pth inter-method adjustment proposed for haemodialysis.
González-Casaus ML; González-Parra E; Sánchez-González C; Albalate M; de la Piedra-Gordo C; Fernández E; Torregrosa V; Rodríguez M; Lorenzo V
Nefrologia; 2014 May; 34(3):330-40. PubMed ID: 24798561
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function.
Gao P; Scheibel S; D'Amour P; John MR; Rao SD; Schmidt-Gayk H; Cantor TL
J Bone Miner Res; 2001 Apr; 16(4):605-14. PubMed ID: 11315988
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone assays--evolution and revolutions in the care of dialysis patients.
Malluche HH; Mawad H; Trueba D; Monier-Faugere MC
Clin Nephrol; 2003 May; 59(5):313-8. PubMed ID: 12779091
[TBL] [Abstract][Full Text] [Related]
20. New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure.
Goodman WG
Kidney Int Suppl; 2003 Nov; (87):S120-4. PubMed ID: 14531784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
